4.4 Article

Estimating individualized treatment effects from randomized controlled trials: a simulation study to compare risk-based approaches

Journal

BMC MEDICAL RESEARCH METHODOLOGY
Volume 23, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12874-023-01889-6

Keywords

Treatment effect heterogeneity; Absolute benefit; Prediction models

Ask authors/readers for more resources

This study compared easily applicable risk-based methods to find optimal prediction methods for individualized treatment effects. The linear-interaction model showed optimal or close-to-optimal performance in many simulation scenarios. The restricted cubic splines model was optimal for strong non-linear deviations when sample size was larger.
Background Baseline outcome risk can be an important determinant of absolute treatment benefit and has been used in guidelines for personalizing medical decisions. We compared easily applicable risk-based methods for optimal prediction of individualized treatment effects. Methods We simulated RCT data using diverse assumptions for the average treatment effect, a baseline prognostic index of risk, the shape of its interaction with treatment (none, linear, quadratic or non-monotonic), and the magnitude of treatment-related harms (none or constant independent of the prognostic index). We predicted absolute benefit using: models with a constant relative treatment effect; stratification in quarters of the prognostic index; models including a linear interaction of treatment with the prognostic index; models including an interaction of treatment with a restricted cubic spline transformation of the prognostic index; an adaptive approach using Akaike's Information Criterion. We evaluated predictive performance using root mean squared error and measures of discrimination and calibration for benefit. Results The linear-interaction model displayed optimal or close-to-optimal performance across many simulation scenarios with moderate sample size (N = 4,250; similar to 785 events). The restricted cubic splines model was optimal for strong non-linear deviations from a constant treatment effect, particularly when sample size was larger (N = 17,000). The adaptive approach also required larger sample sizes. These findings were illustrated in the GUSTO-I trial. Conclusions An interaction between baseline risk and treatment assignment should be considered to improve treatment effect predictions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available